TKECF yields 49.38% · PFE yields 6.13%● Live data
📍 TKECF pulled ahead of the other in Year 1
Combined, TKECF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKECF + PFE for your $10,000?
Tokyo Electric Power Company Holdings, Incorporated, together with its subsidiaries, generates, transmits, distributes, and retails electric power in Japan and internationally. It engages in the domestic and overseas power generation business comprising nuclear power, fuel, and thermal power, as well as solar, geothermal, hydro, and offshore wind power generation; procurement, transportation, and trading of fuel; and provision of consulting services for electricity companies. The company also engages in real estate rental; and sale of gas business. In addition, it provides support services, including planning for ODA or development banks comprising national-level facilities and preliminary surveys, cost reduction programs for individual companies, and human resource development support. The company was formerly known as Tokyo Electric Power Company, Incorporated and changed its name to Tokyo Electric Power Company Holdings, Incorporated in April 2016. The company was incorporated in 1951 and is headquartered in Tokyo, Japan. Tokyo Electric Power Company Holdings, Incorporated is a subsidiary of Nuclear Damage Compensation and Decommissioning Facilitation Corporation.
Full TKECF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.